Association between new-onset atrial fibrillation and dementia among individuals with type 2 diabetes
Zhou Y, Xu M, Yin X, Gong Y
Diabetes Obes Metab. Pub. online 14 Jun 2024.
Leggi
Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study
Yang K, Yang X, Jin C, et al.
BMJ. Pub. online 12 Jun 2024.
Leggi
The effect of eicosapentaenoic and docosahexaenoic acid supplementation on coronary artery calcium progression in subjects with diabetes and coronary artery disease: a secondary analysis of a randomized trial
Asbeutah AA, Daher R, Malik A, et al.
Am J Cardiol. Pub. online 15 Jun 2024.
Leggi
The association between breakfast frequency and diabetes incidence in middle-age women; the results of MTC study
Martínez CF, Stern D, Cortés-Valencia A, et al.
Nutr Metab Cardiovasc Dis. Pub. online 13 Jun 2024.
Leggi
ANNALI AMD: REPORT ANALISI BUSINESS INTELLIGENCE – TERAPIA CON GLP1-RA
Carissimi Soci, siamo lieti di condividere il report dell’analisi di business intelligence, messo a punto dal gruppo Intelligenza Artificiale e basato sui dati degli Annali AMD: “Fotografia dei pazienti con diabete tipo 2 trattati con analoghi del GLP1 e modalità d’intensificazione terapeutica”. In letteratura vi sono molti studi sull'utilizzo in real life…
Leggi
AIFA: Riclassificazione KERENDIA (finerenone): medicinale soggetto a prescrizione medica limitativa, vendibile al pubblico su prescrizione di centri ospedalieri o di specialista endocrinologo, internista, geriatra e nefrologo (RRL). È istituito un piano terapeutico web-based
AIFA. 07/06/2024
Leggi
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary
European Association for the Study of the Liver; European Association for the Study of Diabetes; European Association for the Study of Obesity; Clinical Practice Guideline Panel
Diabetologia. Pub. Online13 Jun 2024.
Leggi
Data-driven phenotyping of presymptomatic type 1 diabetes using longitudinal autoantibody profiles
Ghalwash M, Anand V, Ng K, et al.
Diabetes Care. Pub. online 11 Jun 2024.
Leggi
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study
Napoli R, Nicolucci A, Larosa M, et al.
Diabetes Obes Metab. Pub. online 10 Jun 2024.
Leggi
Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective
Del Prato S, Giorgino F, Szafranski K, Poon Y
Diabetes Obes Metab. Pub. online 10 Jun 2024.
Leggi